Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy

Area of Science:

• Neuroscience
• Proteomics
• Genetics

Background:

• α-synuclein protein is implicated in Parkinson's disease pathogenesis.
• Mechanisms underlying α-synuclein's role in disease progression are not fully understood.

Purpose of the Study:

• Identify pathogenic pathways and therapeutic targets for α-synucleinopathies.
• Investigate the role of GTP cyclohydrolase (GCH1) and folate metabolism in neurotoxicity.

Main Methods:

• Proteomic analysis in a Drosophila model of α-synucleinopathy.
• Gene Ontology enrichment analysis and integration with human genetic studies.
• Comparative proteomic analysis with tauopathy models.

Main Results:

• Identified significant changes in protein expression in α-synucleinopathy flies.
• GTP cyclohydrolase (GCH1) and folate metabolism identified as potential mediators of neurotoxicity.
• GCH1 knockdown exacerbated deficits, while folate supplementation improved outcomes; mitochondrial dysfunction implicated.

Conclusions:

• An integrative approach using proteomics and genetics can identify therapeutic targets.
• GCH1 and folate metabolism represent potential therapeutic avenues for Parkinson's disease.
• Mitochondrial dysfunction is a shared mechanism in neurodegeneration.